AAAAAA
Results:
1-11
|
Results: 11
Authors:
HUDIS C
RICCO L
SEIDMAN A
BASELGA J
CURRIE V
FENNELLY D
GILEWSKI T
LEBWOHL D
MOYNAHAN M
RAPTIS G
SURBONE A
SKLARIN N
YAO TJ
KEEFE D
NORTON L
Citation: C. Hudis et al., LACK OF INCREASED CARDIAC TOXICITY WITH SEQUENTIAL DOXORUBICIN AND PACLITAXEL, Cancer investigation, 16(2), 1998, pp. 67-71
Authors:
HOFF PM
VALERO V
HOLMES FA
WHEALIN H
HUDIS C
HORTOBAGYI GN
Citation: Pm. Hoff et al., PACLITAXEL-INDUCED PANCREATITIS - A CASE-REPORT, Journal of the National Cancer Institute, 89(1), 1997, pp. 91-93
Authors:
HUDIS C
RICCIO L
HOLMES F
SEIDMAN A
BASELGA J
CURRIE V
FENNELLY D
GILEWSKI T
MOYNAHAN M
RAPTIS G
SKLARIN N
SURBONE A
UHLENHOPP M
MAICKEL N
YAO TJ
HELLMAN S
USAKEWICZ J
HORTOBAGYI G
NORTON L
Citation: C. Hudis et al., PHASE-II STUDY OF SEMISYNTHETIC PACLITAXEL IN METASTATIC BREAST-CANCER, European journal of cancer, 33(13), 1997, pp. 2198-2202
Authors:
SMITH C
SCHWARTZ MK
DNISTRIAN A
HUDIS C
SCHWARTZ DL
MORRIS D
Citation: C. Smith et al., EVALUATION OF THE CA15-3(TM) ASSAY (BREAST-CANCER MARKER) ON THE TECHNICON IMMUNO-1(R) SYSTEM, Clinical chemistry, 43, 1997, pp. 599-599
Authors:
HUDIS C
Citation: C. Hudis, NEW APPROACHES TO ADJUVANT CHEMOTHERAPY FOR BREAST-CANCER, Pharmacotherapy, 16(3), 1996, pp. 88-93
Authors:
HUDIS C
SEIDMAN A
RAPTIS G
FENNELLY D
GILEWSKI T
BASELGA J
THEODOULOU M
SKLARIN N
MOYNAHAN M
SURBONE A
CURRIE V
LEBWOHL D
UHLENHOPP M
CROWN J
NORTON L
Citation: C. Hudis et al., SEQUENTIAL ADJUVANT THERAPY - THE MEMORIAL-SLOAN-KETTERING-CANCER-CENTER EXPERIENCE, Seminars in oncology, 23(1), 1996, pp. 58-64
Authors:
VAHDAT L
RAPTIS G
FENNELLY D
HAMILTON N
REICH L
TIERSTEN A
HARRISON M
HUDIS C
MOORE M
YAO TJ
NORTON L
CROWN J
Citation: L. Vahdat et al., RAPIDLY CYCLED COURSES OF HIGH-DOSE ALKYLATING-AGENTS SUPPORTED BY FILGRASTIM AND PERIPHERAL-BLOOD PROGENITOR CELLS IN PATIENTS WITH METASTATIC BREAST-CANCER, Clinical cancer research, 1(11), 1995, pp. 1267-1273
Authors:
SEIDMAN AD
TIERSTEN A
HUDIS C
GOLLUB M
BARRETT S
YAO TJ
LEPORE J
GILEWSKI T
CURRIE V
CROWN J
HAKES T
BASELGA J
SKLARIN N
MOYNIHAN ME
TONG W
EGORIN M
KEARNS C
SPRIGGS D
NORTON L
Citation: Ad. Seidman et al., PHASE-II TRIAL OF PACLITAXEL BY 3-HOUR INFUSION AS INITIAL AND SALVAGE CHEMOTHERAPY FOR METASTATIC BREAST-CANCER, Journal of clinical oncology, 13(10), 1995, pp. 2575-2581
Authors:
RAPTIS G
TIERSTEN A
SHAPIRO F
SCHNEIDER J
HAMILTON N
REICH L
WUEST D
GUCCIARDO A
QUIGUYAN L
GILEWSKI T
BASELGA J
THEODOULOU M
HUDIS C
SURBONE A
MOORE M
CROWN J
NORTON L
Citation: G. Raptis et al., RAPID HEMATOLOGIC RECOVERY FOLLOWING CD34-BLOOD PROGENITOR-CELL (PBPC) PLUS FILGRASTIM (G) RESCUE OF SEQUENTIAL HIGH-DOSE CHEMOTHERAPY (HDC) IN PATIENTS (PTS) WITH METASTATIC BREAST-CANCER (MBC)( SELECTED VERSUS UNSELECTED PERIPHERAL), Blood, 86(10), 1995, pp. 1601-1601
Authors:
HUDIS C
Citation: C. Hudis, IS THERE AN ALTERNATIVE TO ALTERNATING ADJUVANT THERAPY FOR BREAST-CANCER, Cancer investigation, 12(3), 1994, pp. 329-335
Authors:
CROWN J
KRITZ A
VAHDAT L
REICH L
MOORE M
HAMILTON N
SCHNEIDER J
HARRISON M
GILEWSKI T
HUDIS C
GULATI S
NORTON L
Citation: J. Crown et al., RAPID ADMINISTRATION OF MULTIPLE CYCLES OF HIGH-DOSE MYELOSUPPRESSIVECHEMOTHERAPY IN PATIENTS WITH METASTATIC BREAST-CANCER, Journal of clinical oncology, 11(6), 1993, pp. 1144-1149
Risultati:
1-11
|